Atherosclerosis Residual Lipid Risk-Overview of Existing and Future Pharmacotherapies
Patients with atherosclerotic disease remain at increased risk of future events despite receiving optimal medical treatment. This residual risk is widely heterogeneous, but lipoprotein particles and their content play a major role in determining future cardiovascular events. Beyond low-density lipop...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2024-04-01
|
| Rangatū: | Journal of Cardiovascular Development and Disease |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/2308-3425/11/4/126 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|